...
首页> 外文期刊>Journal of drugs in dermatology: JDD >Treating Inflammation in Rosacea: Current Options and Unmet Needs
【24h】

Treating Inflammation in Rosacea: Current Options and Unmet Needs

机译:在Rosacea治疗炎症:目前的选择和未满足的需求

获取原文
获取原文并翻译 | 示例
           

摘要

Rosacea is a disease resulting from dysregulation of innate, adaptive, and neurovascular immune systems. Inflammatory pathways activated in rosacea can explain many of its signs and symptoms. Current treatments address some of these inflammatory processes, alleviating erythema and decreasing papules and pustules. However, for the majority of patients, complete clearance of these features is not currently achievable even with combination therapy. There is a need to address the spectrum of inflammatory processes involved in rosacea and for more efficacious agents with the goal of providing complete clearance for patients.
机译:Rosacea是一种由先天性,适应性和神经血管免疫系统的失调引起的疾病。 在Rosacea中激活的炎症途径可以解释其许多迹象和症状。 目前的治疗解决了一些这些炎症过程,减轻了红斑和减少丘疹和脓疱。 然而,对于大多数患者来说,即使结合治疗,目前无法实现这些功能的完全清除。 需要解决涉及波斯卡科的炎症过程的光谱,并且具有更有效的药剂,其目的是为患者提供完全清关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号